Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Dipanjan Banchur

Is Pfizer Stock Underperforming the Nasdaq?

New York-based Pfizer Inc. (PFE), renowned as one of the world’s largest pharmaceutical companies, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Valued at $161.95 billion by market cap, the company offers medicines and vaccines in various therapeutic areas, including oncology, inflammation and immunology, rare diseases, hospital, vaccines and internal medicine.

Companies worth $10 billion or more are generally described as “large-cap stocks,” PFE fits right into that category. The company, popular for developing the first mRNA vaccine against COVID-19, is celebrating its 175th anniversary this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.